These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
254 related articles for article (PubMed ID: 12695249)
1. The risk and natural course of age-related maculopathy: follow-up at 6 1/2 years in the Rotterdam study. van Leeuwen R; Klaver CC; Vingerling JR; Hofman A; de Jong PT Arch Ophthalmol; 2003 Apr; 121(4):519-26. PubMed ID: 12695249 [TBL] [Abstract][Full Text] [Related]
2. Incidence and progression rates of age-related maculopathy: the Rotterdam Study. Klaver CC; Assink JJ; van Leeuwen R; Wolfs RC; Vingerling JR; Stijnen T; Hofman A; de Jong PT Invest Ophthalmol Vis Sci; 2001 Sep; 42(10):2237-41. PubMed ID: 11527936 [TBL] [Abstract][Full Text] [Related]
3. Five-year incidence of age-related maculopathy: the Visual Impairment Project. Mukesh BN; Dimitrov PN; Leikin S; Wang JJ; Mitchell P; McCarty CA; Taylor HR Ophthalmology; 2004 Jun; 111(6):1176-82. PubMed ID: 15177968 [TBL] [Abstract][Full Text] [Related]
4. Fifteen-year cumulative incidence of age-related macular degeneration: the Beaver Dam Eye Study. Klein R; Klein BE; Knudtson MD; Meuer SM; Swift M; Gangnon RE Ophthalmology; 2007 Feb; 114(2):253-62. PubMed ID: 17270675 [TBL] [Abstract][Full Text] [Related]
5. Retinal vessel diameters and the risk of incident age-related macular disease: the Rotterdam Study. Ikram MK; van Leeuwen R; Vingerling JR; Hofman A; de Jong PT Ophthalmology; 2005 Apr; 112(4):548-52. PubMed ID: 15808242 [TBL] [Abstract][Full Text] [Related]
6. Ten-year incidence and progression of age-related maculopathy: the blue Mountains Eye Study. Wang JJ; Rochtchina E; Lee AJ; Chia EM; Smith W; Cumming RG; Mitchell P Ophthalmology; 2007 Jan; 114(1):92-8. PubMed ID: 17198852 [TBL] [Abstract][Full Text] [Related]
7. Age-related macular degeneration and risk factors for the development of choroidal neovascularisation in the fellow eye: a 3-year follow-up study. Silva R; Cachulo ML; Fonseca P; Bernardes R; Nunes S; Vilhena N; Faria de Abreu JR Ophthalmologica; 2011; 226(3):110-8. PubMed ID: 21822000 [TBL] [Abstract][Full Text] [Related]
8. 5-year incidence of age-related maculopathy in the Reykjavik Eye Study. Jonasson F; Arnarsson A; Peto T; Sasaki H; Sasaki K; Bird AC Ophthalmology; 2005 Jan; 112(1):132-8. PubMed ID: 15629833 [TBL] [Abstract][Full Text] [Related]
9. Cardiovascular risk factors and the long-term incidence of age-related macular degeneration: the Blue Mountains Eye Study. Tan JS; Mitchell P; Smith W; Wang JJ Ophthalmology; 2007 Jun; 114(6):1143-50. PubMed ID: 17275090 [TBL] [Abstract][Full Text] [Related]
10. 14-year incidence, progression, and visual morbidity of age-related maculopathy: the Copenhagen City Eye Study. Buch H; Nielsen NV; Vinding T; Jensen GB; Prause JU; la Cour M Ophthalmology; 2005 May; 112(5):787-98. PubMed ID: 15878058 [TBL] [Abstract][Full Text] [Related]
11. Risk factors for incident age-related macular degeneration: pooled findings from 3 continents. Tomany SC; Wang JJ; Van Leeuwen R; Klein R; Mitchell P; Vingerling JR; Klein BE; Smith W; De Jong PT Ophthalmology; 2004 Jul; 111(7):1280-7. PubMed ID: 15234127 [TBL] [Abstract][Full Text] [Related]
12. Risk of age-related macular degeneration in eyes with macular drusen or hyperpigmentation: the Blue Mountains Eye Study cohort. Wang JJ; Foran S; Smith W; Mitchell P Arch Ophthalmol; 2003 May; 121(5):658-63. PubMed ID: 12742843 [TBL] [Abstract][Full Text] [Related]
13. The three-year incidence of age-related macular degeneration: the "Pathologies Oculaires Liées à l'Age" (POLA) prospective study. Delcourt C; Lacroux A; Carrière I; Am J Ophthalmol; 2005 Nov; 140(5):924-6. PubMed ID: 16310477 [TBL] [Abstract][Full Text] [Related]
14. The prevalence of age-related maculopathy: the visual impairment project. VanNewkirk MR; Nanjan MB; Wang JJ; Mitchell P; Taylor HR; McCarty CA Ophthalmology; 2000 Aug; 107(8):1593-600. PubMed ID: 10919916 [TBL] [Abstract][Full Text] [Related]
15. Sunlight and the 10-year incidence of age-related maculopathy: the Beaver Dam Eye Study. Tomany SC; Cruickshanks KJ; Klein R; Klein BE; Knudtson MD Arch Ophthalmol; 2004 May; 122(5):750-7. PubMed ID: 15136324 [TBL] [Abstract][Full Text] [Related]
16. Characteristics of progression of early age-related macular degeneration: the cardiovascular health and age-related maculopathy study. Tikellis G; Robman LD; Dimitrov P; Nicolas C; McCarty CA; Guymer RH Eye (Lond); 2007 Feb; 21(2):169-76. PubMed ID: 16732219 [TBL] [Abstract][Full Text] [Related]
17. Is medication use associated with the incidence of early age-related maculopathy? Pooled findings from 3 continents. van Leeuwen R; Tomany SC; Wang JJ; Klein R; Mitchell P; Hofman A; Klein BE; Vingerling JR; Cumming RG; de Jong PT Ophthalmology; 2004 Jun; 111(6):1169-75. PubMed ID: 15177967 [TBL] [Abstract][Full Text] [Related]
18. Risk of age-related macular degeneration 3 years after cataract surgery: paired eye comparisons. Wang JJ; Fong CS; Rochtchina E; Cugati S; de Loryn T; Kaushik S; Tan JS; Arnold J; Smith W; Mitchell P Ophthalmology; 2012 Nov; 119(11):2298-303. PubMed ID: 22959104 [TBL] [Abstract][Full Text] [Related]
19. Ten-year incidence and progression of age-related maculopathy: The Beaver Dam eye study. Klein R; Klein BE; Tomany SC; Meuer SM; Huang GH Ophthalmology; 2002 Oct; 109(10):1767-79. PubMed ID: 12359593 [TBL] [Abstract][Full Text] [Related]
20. Four-year incidence and progression of age-related macular degeneration: the Los Angeles Latino Eye Study. Varma R; Foong AW; Lai MY; Choudhury F; Klein R; Azen SP; Am J Ophthalmol; 2010 May; 149(5):741-51. PubMed ID: 20399926 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]